Cresco Capital Partners II, a 10% Holder, acquired 14,960,957 Subordinate Voting Shares on a direct ownership basis at a price of US$0.350 through a prospectus or prospectus exempt offering on April 29th, 2022. This represents a $6,698,320 investment into the company's shares and an account share holdings change of greater than 100%.
Harborside is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.
Harborside Inc. is a Canada-based cannabis company. The Company operates 11 dispensaries covering Northern and Southern California and one in Oregon, as well as a manufacturing facility in Oakland, California, distribution facilities in San Jose and Los Angeles, California and an integrated cultivation/production facility in Salinas, California. The Company holds cannabis licenses for retail, distribution, cultivation, nursery and manufacturing. The Company has a portfolio of approximately four owned brands, including Sublime, Key, Harborside and Loudpack. Harborside Inc. (HBOR) has below median officer and director direct ownership compared to its small-cap peers in the market, based on our estimate using SEDI data. According to regulatory filings yesterday, two insiders have invested a net amount of $6,698,320.
No Comments